Clinical trials of Israeli coronavirus vaccine underway
November 13, 2020
(JNS) - The first Israeli SARS-CoV-2 vaccine was administered at Sheba Medical Center at Tel Hashomer in Ramat Gan on Sunday to the first volunteer in a clinical trial.
The vaccine, called "BriLife," was developed by the Israel Institute of Biological Research, which has prepared 25,000 doses ahead of the 80-person trial. Half of the volunteers will be given the vaccine (or a placebo) at Hadassah University Medical Center in Jerusalem and half at Sheba Medical Center.
In the first stage of the trials, the volunteers, ages 18 to 55, will be monitored for antibodies and side effects for three...